Search Results - "Jiménez‐Bárcenas, Reyes"

Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus by González-López, Tomás José, Bárez, Abelardo, Bernardo-Gutiérrez, Ángel, Bernat, Silvia, Fernández-Fuertes, Fernando, Guinea de Castro, José María, Jiménez-Bárcenas, Reyes, Jarque, Isidro

“…Immune thrombocytopenia (ITP) is a common autoimmune hematological disorder. Despite this, diagnosis is still challenging due to clinical heterogeneity and the…”
Get full text

Novel Therapies to Address Unmet Needs in ITP by Mingot-Castellano, María Eva, Bastida, José María, Caballero-Navarro, Gonzalo, Entrena Ureña, Laura, González-López, Tomás José, González-Porras, José Ramón, Butta, Nora, Canaro, Mariana, Jiménez-Bárcenas, Reyes, Gómez del Castillo Solano, María del Carmen, Sánchez-González, Blanca, Pascual-Izquierdo, Cristina

“…Primary immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts and subsequent bleeding risk. Although current…”
Get full text

COVID-19 Vaccines and Autoimmune Hematologic Disorders by Mingot-Castellano, María Eva, Butta, Nora, Canaro, Mariana, Gómez del Castillo Solano, María, Sánchez-González, Blanca, Jiménez-Bárcenas, Reyes, Pascual-Izquierdo, Cristina, Caballero-Navarro, Gonzalo, Entrena Ureña, Laura, José González-López, Tomás

“…Worldwide vaccination against SARS-CoV-2 has allowed the detection of hematologic autoimmune complications. Adverse events (AEs) of this nature had been…”
Get full text

Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group by González-López, Tomás José, Bárez, Abelardo, Bernardo-Gutiérrez, Angel, Bernat, Silvia, Canaro-Hirnyk, Mariana, Entrena-Ureña, Laura, Fernández-Fuertes, Fernando, Guinea de Castro, José María, Jiménez-Bárcenas, Reyes, Pascual-Izquierdo, Cristina, Sánchez-González, Blanca, Jarque, Isidro

“…Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease with highly variable presentation, characteristics, and clinical course…”
Get full text

Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur Study by Mingot-Castellano, María Eva, García-Donas, Gloria, Campos-Álvarez, Rosa María, de Mora, María Carmen Fernández-Sánchez, Luis-Navarro, Josefa, Domínguez-Rodríguez, Juan Francisco, del Mar Nieto-Hernández, María, Sánchez-Bazán, Irene, Yera-Cobo, Maria, Cardesa-Cabrera, Rocio, Jiménez-Gonzalo, Francisco José, Caparrós-Miranda, Isabel, Entrena-Ureña, Laura, Herrera, Sergio Jurado, Fernández Jiménez, Dolores, Díaz-Canales, Dana, Moreno-Carrasco, Gloria, Calderón-Cabrera, Cristina, Núñez-Vázquez, Ramiro José, Pedrote-Amador, Begoña, Jiménez Bárcenas, Reyes

“…Background/objectives: Fostamatinib is a spleen tyrosine kinase (SYK) inhibitor approved for the treatment of adult patients with chronic immune…”
Get full text

Primary and secondary immune thrombocytopenia (ITP): Time for a rethink by González-López, Tomás José, Provan, Drew, Bárez, Abelardo, Bernardo-Gutiérrez, Angel, Bernat, Silvia, Martínez-Carballeira, Daniel, Jarque-Ramos, Isidro, Soto, Inmaculada, Jiménez-Bárcenas, Reyes, Fernández-Fuertes, Fernando

“…There are not many publications that provide a holistic view of the management of primary and secondary ITP as a whole, reflecting the similarities and…”
Get full text

Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain—The Fostasur Study by Jiménez‐Bárcenas, Reyes, García‐Donas‐Gabaldón, Gloria, Campos‐Álvarez, Rosa María, Fernández‐Sánchez de Mora, María Carmen, Luis‐Navarro, Josefa, Domínguez‐Rodríguez, Juan Francisco, Nieto‐Hernández, María del Mar, Sánchez‐Bazán, Irene, Yera‐Cobo, Maria, Cardesa‐Cabrera, Rocio, Jiménez‐Gonzalo, Francisco José, Ruiz‐Cobo, María Antonia, Caparrós‐Miranda, Isabel, Entrena‐Ureña, Laura, Fernández Jiménez, Dolores, Díaz‐Canales, Dana, Moreno‐Carrasco, Gloria, Calderón‐Cabrera, Cristina, Núñez‐Vázquez, Ramiro José, Pedrote‐Amador, Begoña, Mingot‐Castellano, María Eva

“…Summary Immune thrombocytopenia (ITP) is characterized by low platelet counts (PLTs) and an increased risk of bleeding. Fostamatinib, a spleen tyrosine kinase…”
Get full text

Avatrombopag in immune thrombocytopenia: A real‐world study of the Spanish ITP Group (GEPTI) by Pascual‐Izquierdo, Cristina, Sánchez‐González, Blanca, Canaro‐Hirnyk, Mariana‐Isabel, García‐Donas, Gloria, Menor‐Gómez, María, Gil‐Fernández, Juan‐José, Monsalvo‐Saornil, Silvia, de‐Laiglesia, Almudena, Álvarez‐Román, María‐Teresa, Jarque‐Ramos, Isidro, Llácer, María‐José, Pedrote‐Amador, Begoña, Zafra‐Torres, Denis, Caparrós‐Miranda, Isabel, Ortúzar‐Pasalodos, Ariana, Revilla‐Calvo, Nuria, Bastida, José‐María, Chica‐Gullón, Esther, Alvarellos, Montserrat, Jiménez‐Bárcenas, Reyes, Bernat, Silvia, Martínez‐Carballeira, Daniel, Lakhwani, Sunil, López‐Ansoar, Elsa, Moreno‐Beltrán, María‐Esperanza, Lorenzo‐Vizcaya, Álvaro, Aguirre, María‐Aránzazu, Lasa‐Eguialde, Maialen, Canet, Marta, González‐Gascón‐y‐Marín, Isabel‐Teresa, Caballero‐Navarro, Gonzalo, Cuesta, Amalia, Díaz‐López, Marta, Arquero, Teresa, Moreno‐Carbonell, Marta, Mingot‐Castellano, María‐Eva

“…Avatrombopag is the newest thrombopoietin receptor agonist (TPO‐RA) approved to treat immune thrombocytopenia (ITP). Real‐world evidence regarding…”
Get full text

Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with pre‐existing primary immune thrombocytopenia (ITP) in Spain by Mingot‐Castellano, María E., Alcalde‐Mellado, Patricia, Pascual‐Izquierdo, Cristina, Perez Rus, Gloria, Calo Pérez, Aida, Martinez, María P., López‐Jaime, Francisco J., Abalo Perez, Lorena, Gonzalez‐Porras, José R., López Fernández, Fernanda, Caparrós Miranda, Isabel S., González‐López, Tomás J., Moreno Beltrán, María E., Rubio Escuin, Rebeca, Jimenez Bárcenas, Reyes

“…Summary Infections are one of the well‐known precipitating factors for relapses in patients with immune thrombocytopenia (ITP). Severe acute respiratory…”
Get full text

P1614: TAPERING SCHEME AND SUSTAINED RESPONSE IN PATIENTS WITH ITP TREATED WITH FOSTAMATINIB by Mingot‐Castellano, María Eva, Gabaldon, Gloria García‐Donas, Campos‐Álvarez, Rosa María, Pedrote‐Amador, Begoña, Navarro, Josefa Luis, Cobo, María Yera, Carrasco, Gloria Moreno, Jimenez‐Bárcenas, Reyes

Get full text

Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia by González-López, Tomás José, Sánchez-González, Blanca, Pascual, Cristina, Arefi, Maryam, de Cabo, Erik, Alonso, Arancha, Martín-Salces, Mónica, Jiménez-Bárcenas, Reyes, Calbacho, María, Galan, Pilar, Barez, Abelardo, González-Porras, José Ramón

“…Abstract Eltrombopag is effective and safe in chronic immune thrombocytopenia (ITP) patients not responding to previous therapy. However, when eltrombopag is…”
Get full text

Interaction between capecitabine and brivudin in a patient with breast cancer by Martinez, Maria J, Muriel-Cueto, Pedro, Garcia-Olmedo, Obdulia, Baena-Canada, Jose M, Jimenez-Barcenas, Reyes

“…This Case Study describes a patient with breast cancer who was treated with capecitabine and experienced a severe adverse event when treated with brivudin for…”
Get full text

Factor XIII Deficiency As Underlying Cause Of Unexplained Bleeding by Mercado, Marta Ruiz, Cozzarelli, Silvia Verdesoto, Calderón-Cabrera, Cristina, Vázquez, Ramiro Núñez, Bárcenas, Reyes Jiménez, Garrido, Rosario Pérez, Pérez-Simón, Jose Antonio, Rodríguez Martorell, Francisco Javier

“…Factor XIII deficiency (FXIII) is an uncommon coagulation disorder. Congenital FXIII deficiency, generally due to mutations in F13A1 gene, presents with early…”
Get full text

Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice by González-López, Tomás José, Alvarez-Roman, María Teresa, Pascual, Cristina, Sánchez-González, Blanca, Fernández-Fuentes, Fernando, Pérez-Rus, Gloria, Hernández-Rivas, José Angel, Bernat, Silvia, Cortés, Montserrat, Bastida, José María, Martínez-Robles, Violeta, Fernández-Rodríguez, Angeles, Olivera, Pavel, Bolaños, Estefanía, Alonso, Rafael, Entrena, Laura, Gómez-Nuñez, Marta, Bermejo, Nuria, Martínez-Badas, María Paz, Peñarrubia, María Jesús, Alonso, Arancha, Soto, Inmaculada, Yera Cobo, María, Casaus, Alberto, Caparrós, Isabel, Perera, María, Jiménez Bárcenas, Reyes, Heras, Cecilia, Calbacho, María, Tenorio, Maria, Luaña, Armando, Lopez-Ansoar, Elsa, Hermida, Gerardo, García-Frade, Javier, González-Porras, José Ramón, Sanz, Miguel A.

“…Background: Eltrombopag is an oral thrombopoietin receptor agonist (TPO-RA) drug approved in primary chronic ITP. Lack of clinical trials in secondary ITP…”
Get full text

Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia by Mingot-Castellano, María E, Caparrós, Isabel S, Fernández, Fernando, Perera-Alvarez, María del Mar, Jimenez-Bárcenas, Reyes, Casaus García, Alberto, González-Silva, Manuel, Yera-Cobo, María, Nieto-Hernandez, María M, Rodríguez-Fernandez, María J, Díaz-Canales, Dana

“…Thrombopoietin receptor agonist (TPO-RAs) have demonstrated good efficacy and tolerance in clinical trials in refractory chronic primary immune…”
Get full text

Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry by Gonzalez-Lopez, Tomas Jose, Perez Segura, Gloria, Domingo, Abel, Lopez Ansoar, Elsa, Diaz Galvez, Francisco Javier, Jimenez Barcenas, Reyes, Martinez Carballeira, Daniel, De Miguel Llorente, Dunia, Perona Blazquez, Alvaro, Aguilar-Monserrate, Gerardo, Dávila-Valls, Julio, Gonzalez Gascon, Isabel, Cuesta, Amalia, Bengochea Casado, María Luisa, Hermida Fernandez, Gerardo Julio, Alonso Alonso, Jose Maria, Pozas Mañas, Miguel Angel, Torres-Tienza, Ana, Aguilar, Carlos, Fernandez-Jimenez, Dolores, Soto, Inmaculada, Bernat, Silvia

“…Background: Fostamatinib is a splenic tyrosine kinase (SYK) inhibitor that prevents antibody-mediated platelet destruction. This drug has demonstrated to be…”
Get full text

Thrombopoietin Analogs In ITP Patients Daily Practice: Treatment Profile, Efficacy and Safety by Mingot-Castellano, Maria Eva, Diaz-Canales, Dana, Fernandez-Fuertes, Fernando, Perera-Alvarez, Maria, Caparros-Miranda, Isabel, Jimenez-Barcenas, Reyes, Palomo-Bravo, Angeles, Heiniger Mazo, Ana Isabel, ACC, G

“…Thrombopoietin analogues (TPOa) are an effective alternative of treatment in patients with refractary primary immune thrombocytopenia (ITP) or chronic ITP…”
Get full text